These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15228170)

  • 1. Analytic aspects of cyclosporine monitoring, on behalf of the IFCC/IATDMCT Joint Working Group.
    Morris RG; Holt DW; Armstrong VW; Griesmacher A; Napoli KL; Shaw LM;
    Ther Drug Monit; 2004 Apr; 26(2):227-30. PubMed ID: 15228170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin monitoring in Australasia: survey of laboratory practices in 2000.
    Morris RG; Lam AK
    Ther Drug Monit; 2002 Aug; 24(4):471-8. PubMed ID: 12142629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines.
    Morris RG; Ilett KF; Tett SE; Ray JE; Fullinfaw RO; Cooke R; Cook S
    Ther Drug Monit; 2002 Dec; 24(6):677-88. PubMed ID: 12451282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian cyclosporin therapeutic monitoring method survey: 1993.
    Morris RG
    Ther Drug Monit; 1994 Dec; 16(6):564-9. PubMed ID: 7878695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring.
    Morris RG
    Ther Drug Monit; 2000 Apr; 22(2):160-2. PubMed ID: 10774626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
    Elaerts S; Olejnik Y; Bonardet A; Garrigue V; Mourad G; Cristol JP; Dupuy AM
    Transplant Proc; 2005; 37(1):167-71. PubMed ID: 15808583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month.
    Morris RG; Russ GR; Cervelli MJ; Juneja R; McDonald SP; Mathew TH
    Ther Drug Monit; 2002 Aug; 24(4):479-86. PubMed ID: 12142630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A monitoring in Australia: consensus recommendations.
    Morris RG; Tett SE; Ray JE
    Ther Drug Monit; 1994 Dec; 16(6):570-6. PubMed ID: 7878696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.
    Solari SG; Goldberg LR; DeNofrio D; Shaw LM
    Ther Drug Monit; 2005 Aug; 27(4):417-21. PubMed ID: 16044096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
    Olejnik Y; Elaerts S; Bonardet A; Chong G; Mourad G; Cristol JP; Dupuy AM
    Transplant Proc; 2005; 37(1):172-4. PubMed ID: 15808584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is C2 monitoring or another limited sampling strategy superior to C0 monitoring in improving clinical outcomes in adult liver transplant recipients?
    Marin JG; Levine M; Ensom MH
    Ther Drug Monit; 2006 Oct; 28(5):637-42. PubMed ID: 17038878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of nuclear factor of activated T-cell-regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine a.
    Herden U; Kromminga A; Hagel C; Hartleb J; Nashan B; Sterneck M; Fischer L
    Ther Drug Monit; 2011 Apr; 33(2):185-91. PubMed ID: 21383649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12th quality assessment of cyclosporin blood monitoring by 56 Japanese laboratories.
    Takagi H; Uchida K; Takahara S; Takahashi K
    Transplant Proc; 1998 Aug; 30(5):1706-8. PubMed ID: 9723250
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between cyclosporine concentrations obtained using the Roche Cobas Integra and Abbott TDx monoclonal immunoassays in pre-dose and two hour post-dose blood samples from kidney transplant recipients.
    Garrido MJ; Hermida J; Tutor JC
    Ther Drug Monit; 2002 Dec; 24(6):785-8. PubMed ID: 12451297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
    Büchler M; Chadban S; Cole E; Midtvedt K; Thervet E; Prestele H; Keown P
    Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Program of external quality control in cyclosporine dosage: summary and analysis from French laboratories].
    Marquet P; Perrin A; Billaud E; Méninat F; Johnston A; Holt DW; Vassault A
    Ann Biol Clin (Paris); 1999 May; 57(3):360-3. PubMed ID: 10377491
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants.
    John U; Ullrich S; Roskos M; Misselwitz J
    Transplant Proc; 2005 Apr; 37(3):1608-11. PubMed ID: 15866686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor assay based on surface plasmon resonance for the assessment of the complex formation activity of cyclosporin A and its metabolites.
    Vollenbroeker B; Fobker M; Specht B; Bartetzko N; Erren M; Spener F; Hohage H
    Int J Clin Pharmacol Ther; 2003 Jun; 41(6):248-60. PubMed ID: 12816177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of cyclosporine A in rat tissues and human kidney transplant biopsies--a method suitable for small (<1 mg) samples.
    Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; van Gelder T; Sallustio BC
    Ther Drug Monit; 2011 Dec; 33(6):688-93. PubMed ID: 22105584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.